Carmela Mendoza
Carmela Mendoza is a senior reporter for Private Equity International based in London. She first joined PEI in Hong Kong in 2015 and covered Asia. A graduate of Ateneo de Manila University, she previously worked for a digital agency in Singapore focused on government websites and publications covering business, trade and industry, transport, and social development.
The $400m investment in the Abu Dhabi-owned football business values it at $3 billion and will help it expand in China.
Private equity lawyers based in Asia tell Private Equity International that CalPERS’ disclosure of its carried interest data should be viewed from the perspective of returns.
More industry consolidation is expected as Japan reforms its insurance law.
The firm expects to offload its remaining share in the motorcycle maker and raise about $115 million.
The investment in S Chand will be used to scale up operations in both digital and print publishing.
The firm’s acquisition of maternity and baby products retailer Aiyingshi will support value-enhancing initiatives and improve the company’s operational efficiency.
The combined stake accounts for 17.8 percent of Healthscope’s shares.
For private equity in India, general partners are working diligently to improve the previously bumpy situation by taking on a more hands-on approach, finding the ‘right’ partner, and exploring multiple exit options The Emerging Markets Private Equity Association’s (EMPEA) Special Report: Private Equity in India takes a look at the lessons learnt over the past two decades.
Healthcare investor ChrysCapital sold its stake in Delhi-based pharmaceuticals company Mankind Pharma to investment firm Capital International for $190 million.
The alternative investment management firm has appointed Steve An to lead client support and business development at its first office in South Korea.